<DOC>
	<DOCNO>NCT00003123</DOCNO>
	<brief_summary>RATIONALE : Amifostine may effective help blood count return normal treat patient myelodysplastic syndrome . PURPOSE : Phase II trial study effectiveness amifostine treat patient advanced myelodysplastic syndrome .</brief_summary>
	<brief_title>Amifostine Treating Patients With Advanced Myelodysplastic Syndrome</brief_title>
	<detailed_description>OBJECTIVES : I . Determine overall hematologic response rate amifostine patient advance myelodysplastic syndrome . II . Determine toxic effect amifostine patient . OUTLINE : This open label study . Patients receive intravenous amifostine 15 minute three time week . Patients fail respond 8 week undergo dose escalation . Nonresponding patient remove study 12 week . Therapy continue six month respond patient . Patients observe duration response upon therapy discontinuation . Patients relapse therapy resume previous dose . Patients follow death . PROJECTED ACCRUAL : A maximum 36 patient accrue .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven advanced myelodysplastic syndrome ( MDS ) , include : Refractory anemia Refractory anemia ring sideroblast Refractory anemia excess blast Refractory anemia excess blast transformation MDS least bicytopenia No chronic myelomonocytic leukemia No acute leukemia PATIENT CHARACTERISTICS : Age : 17 Performance Status : ECOG 02 Life Expectancy : Greater 6 month Hematopoietic : Hemoglobin le 8.5 g/dL Absolute granulocyte count le 1,000 g/dL Platelet count le 70,000/mm3 Hepatic : No major hepatic problem Renal : No major renal problem Cardiovascular : No major cardiac disease Other : Prior transfusion blood product allow Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Prior cytokine therapy allow Chemotherapy : No prior chemotherapy Endocrine therapy : Prior steroid therapy allow Radiotherapy : Not specify Surgery : Not specify Other : Prior leucovorin calcium pyridoxine allow</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2004</verification_date>
	<keyword>refractory anemia</keyword>
	<keyword>refractory anemia ring sideroblast</keyword>
	<keyword>refractory anemia excess blast</keyword>
	<keyword>refractory anemia excess blast transformation</keyword>
</DOC>